Tim-3 finds its place in the cancer immunotherapy landscape

by Ana Carrizosa Anderson, Nandini Acharya
Published 2020-06-01

Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19

by Ana Carrizosa Anderson, Ernest C Borden, David Kaufman, Michael J Mastrangelo, David R Parkinson, Jon M Wiggington, Jeffrey S Weber
Published 2020-06-01

Endogenous T Cell Receptor Rearrangement Represses Aggressive Central Nervous System Autoimmunity in a TcR-Transgenic Model on the Non-Obese Diabetic Background

by Asmita Pradeep Yeola, Prenitha Mercy Ignatius Arokia Doss, Joanie Baillargeon, Irshad Akbar, Benoit Mailhot, Mohammad Balood, Mohammad Balood, Sébastien Talbot, Ana Carrizosa Anderson, Steve Lacroix, Steve Lacroix, Manu Rangachari, Manu Rangachari
Published 2020-01-01